Skip to main content
. 2017 Nov 16;2(22):e97222. doi: 10.1172/jci.insight.97222

Figure 2. Effect of W-15 and W-18 on opioid receptor–mediated Gαi signaling.

Figure 2

The Gi-mediated inhibition of cAMP production was determined as previously described (911). Both W-15 and W-18 showed no agonist activity at DOR (A), KOR (B), MOR (C), and nociceptin (NOP) (D) receptors and no antagonist activity at DOR (E), KOR (F), or MOR (G) receptors. Normalized results represent mean ± SEM of 3 independent experiments, each performed in triplicate (0% activity for vehicle activity; 100% for reference activity), and were analyzed in Prism.